Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride
{{output}}
Lung cancer is the leading cause of cancer death, and approximately 15% of all lung cancer patients have small-cell lung cancer (SCLC). Although second-line chemotherapy can produce tumor regression, the prognosis is poor. Amrubicin hydrochloride (AMR) is a sy... ...
